News_en

YC Biotech and New Keelung Community Health Care Group announce successful signing event at Bambino Italian Restaurant to promote the application of EG BioMed’s DNA methylation cancer biomarker test in breast cancer. This innovative testing technology has garnered attention in the industry for its “simple, fast, and accurate” features. The breast cancer detection sensitivity and […]

Taipei City – Date September, 2023

Taipei City – Date August 7, 2023

YC Biotech and Xinkang Community Health Care Group have officially joined forces to introduce EG BioMed’s DNA methylation cancer marker testing to a wider audience. The partnership was celebrated with a signing banquet at the Royal Host Restaurant in Luzhou, where both organizations reaffirmed their commitment to advancing early cancer detection through cutting-edge medical technology.

Taichung– Date July, 2023 YC Biotech Co., Ltd. recently partnered with Taichung Yien Clinic to host a successful training program for healthcare professionals, aimed at promoting DNA methylation cancer biomarker testing developed by EG BioMed Co., Ltd. This testing method offers a simple, rapid, and accurate approach, providing patients with a more comfortable diagnostic experience.

YC Biotech and Xinxi Community Health Care Group have officially joined forces to expand access to EG BioMed’s DNA methylation cancer marker testing. The collaboration was celebrated with a signing banquet at Lemon Grass Restaurant in Xinzhuang, where both organizations reaffirmed their shared commitment to enhancing early cancer detection through innovative medical technology. This cutting-edge

YC Biotech has officially signed the “DNA Methylation Cancer Marker Testing Agreement” with multiple clinics within the New Banqiao Health Care Group, marking a significant step forward in the clinical adoption of breast cancer methylation testing. The agreement was formalized during a signing banquet, underscoring a shared commitment to advancing early cancer detection through cutting-edge

YC Biotech and XinLe Community Health Care Group have officially joined forces to advance breast cancer screening, celebrating their partnership with a signing banquet at the renowned “Daddy’s Kitchen” restaurant in Yonghe District. This collaboration will bring cutting-edge breast cancer methylation testing technology to multiple clinics within the XinLe network, offering patients a more precise

YC Biotech has officially signed a strategic cooperation agreement with Worlder Hands Technology, marking a significant step toward advancing the digital transformation of the biotechnology industry. This collaboration brings together YC Biotech’s expertise in new drug development, CRO services, and commercialization planning with Worlder Hands Technology’s proficiency in statistical analysis, metrology, and digital management solutions.

YC Biotech and Happy Taipei Community Health Care Group hosted a signing banquet on the 19th in Taipei City, marking the beginning of a collaboration aimed at introducing EG BioMed’s innovative DNA methylation breast cancer detection technology to the group’s network of clinics. This partnership is set to enhance early breast cancer detection with a